Markus Haas is the Director of Early Valuation at Bayer Pharmaceuticals, a position held since 2020. Previously, they served as a Senior Finance Manager in Business Development at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2015 to 2017. Markus also held various finance roles within Johnson & Johnson, including Country Controller for LifeScan Germany and positions focused on Janssen Business Services and Venture Investments between 2013 and 2015. They earned an Executive MBA from Hult International Business School from 2018 to 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices